Welcome to LookChem.com Sign In|Join Free

CAS

  • or

499216-06-7

Post Buying Request

499216-06-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

499216-06-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 499216-06-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,9,2,1 and 6 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 499216-06:
(8*4)+(7*9)+(6*9)+(5*2)+(4*1)+(3*6)+(2*0)+(1*6)=187
187 % 10 = 7
So 499216-06-7 is a valid CAS Registry Number.

499216-06-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-phenyl-1H-pyrazole-5-carbaldehyde

1.2 Other means of identification

Product number -
Other names 4-Phenyl-1H-pyrazole-3-carbaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:499216-06-7 SDS

499216-06-7Relevant articles and documents

NOVEL VIRAL REPLICATION INHIBITORS

-

Page/Page column 128; 129; 130-131; 137-138, (2014/10/15)

The present invention relates to a series of novel compounds, methods to prevent or treat viral infections in animals by using the novel compounds and to said novel compounds for use as a medicine, more preferably for use as a medicine to treat or prevent viral infections, particularly infections with RNA viruses, more particularly infections with viruses belonging to the family of the Flaviviridae, and yet more particularly infections with the Dengue virus. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of viral infections. The invention also relates to processes for preparation of the compounds.

Synthesis of 3- and 5-formyl-4-phenyl-1H-pyrazoles: Promising head units for the generation of asymmetric imine ligands and mixed metal polynuclear complexes

Olguin, Juan,Brooker, Sally

, p. 1242 - 1253 (2011/08/03)

Two synthetic methodologies are reported for the generation of 4-phenyl-1H-pyrazoles substituted at the 3- and/or 5-positions. Functionalisation of the 4-position of dimethyl-4-iodo-1-(tetrahydropyran-2-yl)- 3,5-pyrazolecarboxylate (10) to produce dimethyl-4-phenyl-1-(tetrahydropyran-2- yl)-3,5-pyrazolecarboxylate (14) was achieved by a C-C Suzuki-Miyaura cross coupling reaction in water. However, low yields for this reaction led us to develop a second methodology wherein functionalisation of N-(tetrahydropyran-2- yl)-4-phenylpyrazole (18), synthesised from inexpensive phenylacetic acid, with formyl or hydroxymethyl groups was achieved by lithiation methods. The resulting monoaldehydes, 4-phenyl-5-pyrazole carbaldehyde (20) and 5-formyl-3-(2′- tetrahydropyranyloxymethyl)-4-phenyl-1-(tetrahydropyran-2-yl)pyrazole (28), should facilitate access to new, asymmetric, imine ligands based on a 4-phenyl-1H-pyrazole moiety. This was proven by the successful synthesis of the heterometallic tetranuclear complex [FeII(NiIIL 2)3](BF4)2·solvents. Likewise, the alcohol isolated en route to 28, N-(tetrahydropyran-2-yl)-5- (hydroxymethyl)-4-phenylpyrazole (24), should facilitate access to new, asymmetric, amine ligands.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 499216-06-7